Description
PremierMax<sup>®</sup>CB is a newly developed biological therapeutic derived from umbilical cord blood having too few cells for a full body transplant.
The lower cell count makes the PremierMax<sup>®</sup>CB product line perfect for smaller, localized treatments.
Each vial of PremierMax<sup>®</sup>CB contains 1mL/1cc of a cellular and protein cocktail that has demonstrated remarkable results in early research testing.
PREMIERMAXCB® comes in 3 doses;
Platinum (an average of 30 Million nucleated cells),
Gold (an average of 15 Million nucleated cells), and
Silver (an average of 8 Million nucleated cells), to allow the clinician to tailor their treatment protocol.
Manufactured under cGMP conditions in our state of the art clean room facility, PremierMax<sup>®</sup>CB is tested to the highest standards for safety, quality, identity, purity, and potency.
PREMIERMAXCB® is currently distributed for research use. An IND application is currently in progress for our Platinum product. Gold and Silver to follow.
